DBV Technologies (DBVT) Net Cash Flow Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | 296.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 296.52% |
| Dec 31, 2025 | 1,242.17% |
| Sep 30, 2025 | -44.27% |
| Jun 30, 2025 | 341.48% |
| Mar 31, 2025 | 45.51% |
| Dec 31, 2024 | 23.31% |
| Sep 30, 2024 | -8.81% |
| Jun 30, 2024 | -90.27% |
| Mar 31, 2024 | -77.23% |
| Dec 31, 2023 | 41.90% |
| Sep 30, 2023 | -0.09% |
| Jun 30, 2023 | -109.78% |
| Mar 31, 2023 | -1,200.00% |
| Dec 31, 2022 | -28.14% |
| Sep 30, 2022 | 13.94% |
| Jun 30, 2022 | 726.77% |
| Mar 31, 2022 | 95.55% |
| Dec 31, 2021 | 44.84% |
| Sep 30, 2021 | 45.37% |
| Mar 31, 2021 | -135.95% |
| Dec 31, 2020 | -127.24% |
| Sep 30, 2020 | 13.61% |
| Dec 31, 2019 | 139.61% |
| Sep 30, 2019 | -270.45% |
| Jun 30, 2019 | -11.49% |
| Dec 31, 2018 | -120.68% |
| Dec 31, 2017 | -96.35% |
| Dec 31, 2016 | -621.40% |
| Dec 31, 2015 | 16.42% |